GlassScriptPhysician profile
Cori Steele
NPI 1982101119
$1,238.53
in general payments reported to CMS, 2019-2025
16 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $297 · 2024: $418 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $314.42 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $186.19 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $143.67 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $139.38 | 2023-2025 | |
| Exact Sciences Corporation | $124.41 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $70.22 | 2023-2025 | Evenity, Prolia, Prolia |
| Phathom Pharmaceuticals, INC. | $51.83 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $36.94 | 2024 | |
| Genzyme Corporation | $36.32 | 2025 | |
| Abbvie INC. | $24.34 | 2025 | |
| Antares Pharma, INC. | $23.63 | 2025 | Xyosted |
| Biogen, INC. | $20.02 | 2025 | Skyclarys |
| Gilead Sciences, INC. | $19.19 | 2023 | Epclusa |
| Merck Sharp & Dohme LLC | $19.10 | 2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Kowa Pharmaceuticals America, INC. | $15.52 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cori Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.